Skip to main content
GYRE
NASDAQ Life Sciences

Wiseek Filing Insight

Analysis by Wiseek.aiReviewed by Editorial Team
Sentiment info
Neutral
Importance info
4
Price
$7.63
Mkt Cap
$740.064M
52W Low
$6.57
52W High
$11.78
Market data snapshot near publication time

check_boxKey Events

  • No key events were highlighted for this filing.

auto_awesomeAnalysis

No analysis available.

At the time of this filing, GYRE was trading at $7.63 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $740.1M. The 52-week trading range was $6.57 to $11.78. This filing was assessed with an importance score of 4 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed GYRE - Latest Insights

GYRE
Apr 27, 2026, 4:30 PM EDT
Filing Type: DEF 14A
Importance Score:
8
GYRE
Apr 16, 2026, 4:13 PM EDT
Filing Type: PRE 14A
Importance Score:
8
GYRE
Mar 23, 2026, 7:51 AM EDT
Filing Type: 8-K
Importance Score:
8
GYRE
Mar 13, 2026, 4:31 PM EDT
Filing Type: 10-K
Importance Score:
8
GYRE
Mar 12, 2026, 6:31 AM EDT
Filing Type: 8-K
Importance Score:
7
GYRE
Mar 12, 2026, 6:01 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
GYRE
Mar 11, 2026, 8:00 PM EDT
Filing Type: 8-K
Importance Score:
7
GYRE
Mar 02, 2026, 9:24 AM EST
Filing Type: 8-K
Importance Score:
9
GYRE
Mar 02, 2026, 8:29 AM EST
Source: Reuters
Importance Score:
9
GYRE
Jan 05, 2026, 7:06 AM EST
Filing Type: 8-K
Importance Score:
8